Search

Search Results
Results 2361 - 2370 of 2563 for Autoimmune disorder
  • News - 21 Nov 2012
    Johns Hopkins researchers report the successful use of a form of MRI to identify what appears to be a key biochemical marker for cognitive impairment in the brains of people with multiple sclerosis...
  • News - 2 Jun 2012
    Results published in Blood, the official journal of the American Society of Hematology, confirm that inhibition of the IRE1a-XBP1 pathway impacts the survival of myeloma cells, suggesting a promising...
  • News - 12 Nov 2010
    The 2010 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) brings together leading allergists and immunologists from around the world.
  • News - 16 Aug 2005
    A new study may one day help those deafened by immune system attack, and possibly also lead to a test that could show which patients may be helped by immediate steroid treatment.
  • News - 28 Mar 2005
    Global health leaders today presented new research showing that vaccinating infants against Streptococcus pneumoniae -- a bacterium that causes deadly pneumonia, meningitis and sepsis -- could...
  • Drug - 2 Jun 2025
    Consumer Medicine Information (CMI) about Shingrix intended for persons living in Australia.
  • Drug - 13 May 2025
    Consumer Medicine Information (CMI) about Amgevita intended for persons living in Australia.
  • Drug - 9 May 2025
    Consumer Medicine Information (CMI) about Remicade intended for persons living in Australia.
  • Drug - 18 Mar 2025
    Consumer Medicine Information (CMI) about Mersynofen intended for persons living in Australia.
  • Drug - 11 Mar 2025
    Consumer Medicine Information (CMI) about Humira intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.